AGE |
Advanced glycation end product |
AMPK |
AMP-activated protein kinase |
ApoE-/- |
Apolipoprotein E knockout |
CaMKK |
Calcium/calmodulin-dependent protein kinase kinase |
cAMP |
Cyclic adenosine monophosphate |
CCL |
Chemokine ligand |
CREB |
cAMP response element-binding protein |
CVD |
Cardiovascular disease |
DPP |
Dipeptidyl peptidase |
ET |
Endothelin |
GIP |
Glucose-dependent insulinotropic polypeptide |
GIPR |
GIP receptor |
GLP-1 |
Glucagon like peptide-1 |
GLP-1RA |
GLP-1 receptor agonist |
HUV |
Human umbilical vein |
IL |
Interleukin |
LDL |
Low density lipoprotein |
LKB |
Liver kinase B |
LPS |
Lipopolysaccharide |
NO |
Nitric oxide |
NOS |
Nitric oxide synthase |
PAI |
Plasminogen activator inhibitor |
PKA |
Protein kinase A |
PLC |
Phospholipase C |
PTA |
Percutaneous transluminal angioplasty |
SMC |
Smooth muscle cell |
TNF |
Tumor necrosis factor |
VEC |
Vascular endothelial cell |
VSMC |
Vascular smooth muscle cell |